AbbVie to Present New Lung Cancer Data at WCLC 2026
AbbVie (ABBV) says it will present new data at the WCLC 2026 show, highlighting innovation across its lung cancer pipeline; no details on results or magnitude were supplied.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.